Commure · 20 hours ago
RCM Account Executive-Remote
Maximize your interview chances
Health CareInnovation Management
Insider Connection @Commure
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Successfully close new business through relationship-based selling
Master the ability to evangelize the Commure + Athelas story
Achieve and exceed monthly and quarterly quotas
Align Commure + Athelas solutions with business objectives and needs
Successfully manage and overcome prospect objections
Collaborate effectively with the account team and others to drive new business
Proactively keep abreast of our industry and the technology landscape to ensure you are a trusted resource to prospects and customers
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Demonstrated experience and success in a health-tech sales role (preferably in RCM or EMR technology)
Demonstrated leadership ability
Tenacious hunger to win business and close deals
Experience with quota and commission compensation structure
Ability to effectively speak with prospects of all levels (including C-level executives)
Excellent written and oral communication skills
Highly organized and strong time management skills
Ability to work in a fast-paced, changing environment
Self-driven, motivated, and results-oriented
Proven prospecting and sales cycle management skills
Proven success in penetrating new markets and closing new business
Must be willing to travel 25% of the time for role
Benefits
Unlimited PTO
Medical
Dental
Vision
Excellent maternity and paternity paid time off
Company
Commure
Commure is healthcare’s first operating system, purpose-built to foster a vibrant health ecosystem by advancing care through collaboration.
Funding
Current Stage
Late StageTotal Funding
$620.5MKey Investors
General Catalyst
2024-05-31Series Unknown· $4.45M
2023-10-13Series Unknown· $70M
2022-01-18Series Unknown· $3.75M
Recent News
BioWorld Financial Watch
2024-12-22
GlobeNewswire News Room
2024-12-20
GlobeNewswire News Room
2024-11-20
Company data provided by crunchbase